News Links
Legislative and Policy News for June 16, 2021
FUTURE Local Coverage Determination (LCD):Glucose Monitors (L33822) Attorney general files lawsuit against insulin manufacturers Mississippi becomes the first state to jointly sue drug makers and PBMs over the cost of insulin
Read MoreCeliac News for June 16, 2021
IBS vs. Celiac Disease: Symptom Comparison Food insecurity is especially difficult for those with food allergies and celiac disease
Read MorePress Releases and Product Information for June 16, 2021
British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy
Read MorePopular Press for June 16, 2021
The COVID-19 virus can cause diabetes, new studies find New research links COVID-19 to Type 1 diabetes diagnosis
Read MoreResearch for June 16, 2021
An in vitro Perfused Macroencapsulation Device to Study Hemocompatibility and Survival of Islet-Like Cell Clusters (HTML) COVID-19 infection as a trigger for new-onset type 1 diabetes in a susceptible individual – or just coincidence? (HTML) Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants (HTML) Is diabetic retinopathy affected by diabetes type? A retrospective study using electronic medical record data from patients with latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes (HTML) Dietary phytochemical index associated with cardiovascular risk factor in patients with type 1 diabetes mellitus […]
Read MoreDaily Care for June 16, 2021
Pathways of emotional autonomy, problem-solving ability, self-efficacy, and self-management on the glycemic control of adolescents with type 1 diabetes: A prospective study (HTML) Dapagliflozin: an effective adjunctive treatment in type 1 diabetes (HTML) A review of risk factors associated with insulin omission for weight loss in type 1 diabetes (HTML) Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: a phase III, randomized, controlled trial (HTML) A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention (HTML) Cross-national […]
Read MoreCeliac News for June 9, 2021
What Is Celiac Disease Rash? Here’s What You Should Know About the Itchy Condition Gluten Intake Not Tied to Cognition in Women Without Celiac Disease
Read MorePress Releases and Product Information for June 9, 2021
Tandem Diabetes Care touts study results for insulin pump with closed-loop technology Dexcom shares clinical data on G7 CGM ahead of next-gen showdown with Abbott Sernova’s Principal Investigator Presents Positive New Data from Ongoing Type 1 Diabetes (T1D) Clinical Trial at ATC 2021 Virtual Connect Conference Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment Blood sugar highs and lows linked to greater dementia risk in type 1 diabetes Measuring gene expression changes over time may help predict T1D diabetes progression
Read More